Cargando…

How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?

Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, card...

Descripción completa

Detalles Bibliográficos
Autores principales: Binnie, Alexandra, Lage, Joel, Dos Santos, Claudia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152028/
http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9
_version_ 1783521385436413952
author Binnie, Alexandra
Lage, Joel
Dos Santos, Claudia C.
author_facet Binnie, Alexandra
Lage, Joel
Dos Santos, Claudia C.
author_sort Binnie, Alexandra
collection PubMed
description Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, cardiac ischemia, bowel perforation, vasculitis, and pulmonary embolism amongst others. Two widely used biomarkers, C-reactive protein and procalcitonin, have proven promising in sepsis diagnosis. Each has found varying success in the clinical context, with some centers relying heavily on these markers and others eschewing their use almost entirely. In this chapter, we present the evidence for their use in the diagnosis of sepsis and management of antibiotic therapy in the intensive care unit context.
format Online
Article
Text
id pubmed-7152028
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-71520282020-04-13 How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation? Binnie, Alexandra Lage, Joel Dos Santos, Claudia C. Evidence-Based Practice of Critical Care Article Diagnosis of sepsis is based on recognition of systemic inflammation and organ failure in the context of an inciting infection. Since none of the diagnostic criteria are specific to sepsis, it is easy to confound sepsis with noninfectious causes of systemic inflammation, including pancreatitis, cardiac ischemia, bowel perforation, vasculitis, and pulmonary embolism amongst others. Two widely used biomarkers, C-reactive protein and procalcitonin, have proven promising in sepsis diagnosis. Each has found varying success in the clinical context, with some centers relying heavily on these markers and others eschewing their use almost entirely. In this chapter, we present the evidence for their use in the diagnosis of sepsis and management of antibiotic therapy in the intensive care unit context. 2020 2019-09-24 /pmc/articles/PMC7152028/ http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9 Text en Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Binnie, Alexandra
Lage, Joel
Dos Santos, Claudia C.
How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title_full How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title_fullStr How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title_full_unstemmed How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title_short How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
title_sort how can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152028/
http://dx.doi.org/10.1016/B978-0-323-64068-8.00055-9
work_keys_str_mv AT binniealexandra howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation
AT lagejoel howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation
AT dossantosclaudiac howcanbiomarkersbeusedtodifferentiatebetweeninfectionandnoninfectiouscausesofinflammation